Pharmacy News

Drug shortages are lasting longer and reach all-time high

In its first report on drug shortages, the U.S. Pharmacopeia (USP) noted that drug shortages are lasting longer than before and are affecting a broad range of therapeutic classes.

CDC recommends doxy PEP for STI prevention

Cases of syphilis, chlamydia, and gonorrhea are on the rise in the United States, but clinical evidence shows that taking doxycycline 200 mg within 72 hours of a sexual encounter can significantly reduce infections.

Report outlines new definition for Long COVID, reviews evidence for diagnosis, risk, and symptoms

Long COVID can cause more than 200 symptoms and it affects each person differently, according to a new report from the National Academies of Sciences, Engineering, and Medicine.

WSU research finds pharmacists prove effective, less costly care option for minor illnesses

Community pharmacist–provided care for minor conditions could be cost-effective, new research shows.

GLP-1 could reduce risk for chronic kidney disease and adverse cardiovascular outcomes

Does taking the GLP-1 receptor agonist semaglutide for blood glucose control also lower the risk of clinically important kidney and cardiovascular outcomes? In the FLOW clinical trial, researchers found that of the 3,533 patients diagnosed with both T2D and chronic kidney disease, those taking semaglutide had a 24% lower risk of a primary-outcome event in the intervention group compared with the controls.